XML 39 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation
 6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]    
SHARE-BASED COMPENSATION

18. SHARE-BASED COMPENSATION

 

The Company accounts for share-based compensation in accordance with ASC 718, Compensation – Stock Compensation. ASC 718 requires companies to measure the cost of employee and non-employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee and non-employee is required to provide service in exchange for the award, usually the vesting period.

 

Share-based compensation for employees and non-employees is recorded in the Consolidated Statement of Operations as a component of general and administrative expense with a corresponding increase to additional paid-in capital in shareholders' equity.

 

Stock Options

 

On March 20, 2019, the Company granted options outside of any equity plan to two employees and one non-employee for the purchase of an aggregate of 180,000 shares of the Company's common stock. All the options have an exercise price of $1.06 per share and expire on March 20, 2023. Under the Black-Scholes option pricing model, the fair value of the 180,000 options on the date of grant was estimated at $123,130.

 

No options were granted during the six months ended June 30, 2020.

 

The following table summarizes the assumptions used to estimate the fair value of stock options granted during the period January 10, 2019 (inception) to June 30, 2019:

 

   2019 
Expected dividend yield   0%
Expected volatility   90%
Risk-free interest rate   2.40-2.47% 
Expected life of options   4.0 years 

   

The following table represents stock option activity for the six months ended June 30, 2020 and the period January 10, 2019 (Inception) to June 30, 2019:

 

   Number of
Options		   Weighted-
Average
Exercise
Price per
Share		   Weighted-
Average
Contractual
Life in
Years		   Aggregate
Intrinsic
Value		 
Outstanding – December 31, 2019   8,695,000   $0.63    1.34   $2,264,760 
Granted   —    —    —    — 
Exercised   —    —    —    — 
Cancelled or Expired   (3,630,000)   0.61    —    — 
Outstanding – June 30, 2020   5,065,000   $0.65    1.69   $2,191,750 
Exercisable – June 30, 2020   5,065,000   $0.65    1.69   $2,191,750 

 

   Number of
Options		   Weighted-
Average
Exercise
Price per
Share		   Weighted-
Average
Contractual
Life in
Years		   Aggregate
Intrinsic
Value		 
Outstanding – January 10, 2019   13,990,000   $0.61    3.15   $— 
Granted   180,000    1.06    —    — 
Exercised   —    —    —    — 
Cancelled or Expired   (50,000)   0.90    —    — 
Outstanding – June 30, 2019   14,120,000   $0.61    1.57   $4,466,080 
Exercisable – June 30, 2019   13,745,000   $0.60    1.56   $4,466,080 

 

For the six months ended June 30, 2020, there were no unvested stock options.

 

The Company did not record any share-based compensation expense for the six months ended June 30, 2020. Compensation expense related to stock options is recorded in share-based compensation expense in the Consolidated Statement of Operations. For the six months ended June 30, 2020 and the period January 10, 2019 (Inception) to June 30, 2019, there was no unrecognized compensation expense related to stock options.

 

Restricted Stock Awards

 

On March 25, 2019, ComSovereign Corp.'s Board of Directors granted an aggregate of 80,000 restricted stock awards ("RSAs") to a non-employee for consulting services, of which 60,000 RSAs immediately vested and 20,000 RSAs vested upon the change in control of ComSovereign in connection with the ComSovereign Acquisition. The grant date fair value of these RSAs was $4.40 per share of common stock for a total value of $352,000. ComSovereign recognized the full $352,000 of stock compensation expense for the RSAs during the period January 10, 2019 (inception) to March 31, 2019. ComSovereign Corp. did not recognize any additional stock compensation expense related to RSAs during the three months ended June 30, 2019.

 

For the six months ended June 30, 2020, the Company did not recognize any expense related to RSAs. For the period January 10, 2019 (Inception) through June 30, 2019, the Company recognized $62,500 compensation expense related to RSAs. See Note 1 – Description of Business and Basis of Presentation for information about the shares issued in connection with the formation of ComSovereign.

 

2020 Long-Term Incentive Plan

 

On April 22, 2020, the Company's Board of Directors adopted the 2020 Long-Term Incentive Plan (the "2020 Plan") which was approved by the stockholders on or about May 6, 2020. Employees, officers, directors and consultants that provide services to the Company or one of its subsidiaries may be selected to receive awards under the 2020 Plan. Awards under the 2020 Plan may be in the form of incentive or nonqualified stock options, stock appreciation rights, stock bonuses, restricted stock, stock units and other forms of awards including cash awards and performance-based awards.

 

A total of 10,000,000 shares of the Company's common stock are authorized for issuance with respect to awards granted under the 2020 Plan. Any shares subject to awards that are not paid, delivered or exercised before they expire or are cancelled or terminated, or fail to vest, as well as shares used to pay the purchase or exercise price of awards or related tax withholding obligations, will become available for other award grants under the 2020 Plan. As of August 15, 2020, no stock grants had been issued under the 2020 Plan, and 10,000,000 shares authorized under the 2020 Plan remained available for award purposes.

 

The 2020 Plan will terminate on May 1, 2030. The maximum term of options, stock appreciation rights and other rights to acquire common stock under the 2020 Plan is ten years after the initial date of the award.

14. SHARE-BASED COMPENSATION

 

Stock Options

 

The following information relates to the stock option activity of the Company prior to the ComSovereign Acquisition.

 

During 2017, the Company granted the following options outside of any equity plan with the attributes described below to purchase the Company’s common stock (amounts in US$’s, except share data):

 

Grant Date   Underlying Shares     Option Price     Full Vesting Date   Expiration Date
January 9, 2017     100,000     $ 2.90     January 9, 2019   January 7, 2021
August 3, 2017     5,130,000     $ 0.50     August 3, 2017   August 3, 2021
November 9, 2017     2,000,000     $ 0.50     November 9, 2017   November 9, 2021
December 13, 2017     200,000     $ 1.00     November 13, 2019   December 13, 2021

 

During 2018, the Company granted the following options outside of any equity plan with the attributes described below to purchase the Company’s common stock (amounts in US$’s, except share data):

 

Grant Date   Underlying Shares     Vesting   Option Price     Full Vesting Date   Expiration Date
March 28, 2018     100,000     50% in one year; 50% in two years from grant date   $ 1.00     March 28, 2020   March 28, 2022
May 16, 2018     330,000     Immediate vesting   $ 1.00     May 16, 2018   May 16, 2022
May 16, 2018     130,000     50% in one year; 50% in two years from grant date   $ 1.00     May 16, 2020   May 16, 2022
September 26, 2018     6,000,000     $4,000,000 new government orders   $ 0.65     December 21, 2018   September 26, 2022

 

All of the above options were outstanding as of January 10, 2019.

 

On March 20, 2019, the Company granted options outside of any equity plan to two employees and one non-employee for the purchase of an aggregate of 180,000 shares of the Company’s common stock. All the options have an exercise price of $1.06 per share and expire on March 20, 2023. Under the Black-Scholes option pricing model, the fair value of the 180,000 options on the date of grant was estimated at $123,130.

 

The following table summarizes the assumptions used to estimate the fair value of stock options granted during fiscal 2019:

 

   2019 
Expected dividend yield   0%
Expected volatility   90%
Risk-free interest rate   2.40-2.47%
Expected life of options   4.0 years 

 

Total recognized compensation expense related to the Company’s stock options was $157,441 for fiscal 2019. All options granted by the Company vested upon the change of control resulting from the completion of the ComSovereign Acquisition on November 27, 2019.

 

The following table represents stock option activity of ComSovereign and the Company as of and for fiscal 2019:

 

   Number of
Options		   Weighted-
Average
Exercise
Price per
Share		   Weighted-
Average
Contractual
Life in
Years		   Aggregate
Intrinsic
Value		 
Outstanding – January 10, 2019   13,990,000   $0.61    3.15   $— 
Granted   180,000    1.06           
Exercised   (5,250,000)   0.57           
Cancelled or Expired   (225,000)   0.72           
Outstanding – December 31, 2019   8,695,000   $0.63    1.34   $2,264,760 
Exercisable – December 31, 2019   8,695,000   $0.63    1.34   $2,264,760 

 

As of December 31, 2019, there were no unvested stock options.

 

The Company did not record any compensation expense for the period from November 27, 2019, the date of the ComSovereign Acquisition, to December 31, 2019. Compensation expense related to stock options would be recorded in general and administrative expense in the Consolidated Statement of Operations. As of December 31, 2019, there was no unrecognized compensation expense related to stock options.

 

Restricted Stock Awards

 

On March 25, 2019, ComSovereign’s Board of Directors granted an aggregate of 80,000 RSAs to a non-employee for consulting services, of which 60,000 RSAs immediately vested and 20,000 RSAs vested upon the change in control of ComSovereign in connection with the ComSovereign Acquisition. The grant date fair value of these RSAs was $4.40 per share of common stock for a total value of $352,000.

 

On November 12, 2019, the Company’s Board of Directors granted an aggregate of 2,300,000 RSAs to eight employees. The RSAs vested upon the change of control upon the completion of the ComSovereign Acquisition on November 27, 2019. The Company recorded $1,495,000 in share-based compensation expense related to these RSAs during fiscal 2019, prior to the ComSovereign Acquisition. No compensation expense was recognized for the period November 27, 2019, the date of the ComSovereign Acquisition, through December 31, 2019. 

 

On November 14, 2019, ComSovereign’s Board of Directors granted an aggregate of 40,000 RSAs to a non-employee for consulting services that vested immediately. The grant date fair value of these RSAs was $4.40 per share of common stock for a total value of $176,000.

 

On November 19, 2019, ComSovereign’s Board of Directors granted an aggregate of 270,800 RSAs to noteholders, employees, non-employees and an officer with a grant date fair value of $4.40 per share of common stock that vested immediately for a total value of $1,191,520.

 

On November 27, 2019, ComSovereign’s Board of Directors granted an aggregate of 50,000 RSAs that immediately vested to a non-employee for assistance in negotiating a secured loan agreement on ComSovereign’s behalf. The grant date fair value of these RSAs was $4.40 per share of common stock for a total value of $220,000.

 

On December 2, 2019, the Company’s Board of Directors granted an aggregate of 1,900,000 RSAs to nine officers and directors. The vesting period for these RSAs is as follows: 850,000 vest on the one-year anniversary of the grant date; 850,000 vest on the two-year anniversary of the original grant date; and 200,000 vest on the three-year anniversary of the original grant date. The Company recognized $54,667 in share-based compensation expense for these RSAs during fiscal 2019 which was recognized after the ComSovereign Acquisition.

 

Total recognized compensation expense related to the RSAs was $258,256 which was recorded in general and administration expense in the Consolidated Statement of Operations. See Note 1 – Description of Business and Basis of Presentation for information about the shares issued in connection with the formation of ComSovereign.

 

See Note 20 – Subsequent Events for information related to the adoption of the 2020 Long-Term Incentive Plan.